|
|
||||||||
1 Department of Medical Physiology, Panum Institute, University of Copenhagen, and 2 Danish Aerospace Medical Centre of Research, Rigshospitalet, DK-2200 Copenhagen; 3 Department of Clinical Physiology, Herlev Hospital, DK-2730 Herlev; and 4 Department of Physiology and Pharmacology, University of Southern Denmark, Odense, DK-5000 Odense, Denmark
| |
ABSTRACT |
|---|
|
|
|---|
The hypothesis that natriuresis can be
induced by stimulation of gastrointestinal osmoreceptors was tested in
eight supine subjects on constant sodium intake (150 mmol NaCl/day). A
sodium load equivalent to the amount contained in 10% of measured
extracellular volume was administered by a nasogastric tube as isotonic
or hypertonic saline (850 mM). In additional experiments, salt loading
was replaced by oral water loading (3.5% of total body water). Plasma
sodium concentration increased after hypertonic saline (+3.1 ± 0.7 mM), decreased after water loading (
3.8 ± 0.8 mM), and
remained unchanged after isotonic saline. Oncotic pressure decreased by
9.4 ± 1.2, 3.7 ± 1.2, and 10.7 ± 1.3%, respectively. Isotonic
saline induced an increase in renal sodium excretion (104 ± 15 to 406 ± 39 µmol/min) that was larger than seen with hypertonic saline (85 ± 15 to 325 ± 39 µmol/min) and water loading (88 ± 11 to 304 ± 28 µmol/min). Plasma ANG II decreased to 22 ± 6, 35 ± 6, and
47 ± 5% of baseline after isotonic saline, hypertonic saline, and
water loading, respectively. Plasma atrial natriuretic peptide (ANP)
concentrations and urinary excretion rates of endothelin-1 were
unchanged. In conclusion, stimulation of osmoreceptors by intragastric
infusion of hypertonic saline is not an important natriuretic stimulus
in sodium-replete subjects. The natriuresis after intragastric salt
loading was independent of ANP but can be explained by inhibition of
the renin-angiotensin system.
hypertonic saline; isotonic saline; angiotensin II; atrial natriuretic peptide; endothelin-1
| |
INTRODUCTION |
|---|
|
|
|---|
A NUMBER OF EXPERIMENTAL results indicate that specific osmoreceptors located somewhere in the intestines or the portal circulation are involved in the control of water and sodium balance (for review, see Refs. 5, 20, 33). Infusion of hypertonic saline directly into the portal circulation has been found to induce an excess natriuresis compared with the response to systemic administration (10, 11, 17, 31, 38). This excess natriuresis after stimulation of gastrointestinal or hepatic osmoreceptors may be mediated through afferent vagal or hepatic fibers (11, 25-28, 31) but may also involve a humoral component, e.g., the renin-angiotensin system (12, 30).
Furthermore, there is indication that oral sodium loading may increase renal sodium excretion to a greater extent than intravenous loading in rats (29), rabbits (8), and humans on low sodium intake (7, 24). However, others have been unable to confirm the physiological importance of gastrointestinal osmoreceptors (4, 16, 18, 23, 32, 34). Very recently, Singer et al. (36) found similar natriuretic responses to oral and intravenous salt loading in subjects on high and very low sodium intakes (36). In subjects on normal sodium intake, oral administration resulted in a delayed natriuretic response that initially was smaller than but after ~3 h exceeded the response to intravenous loading. However, cumulated sodium excretions were statistically identical, irrespective of initial sodium status (36).
Although there is evidence favoring that stimulation of gastrointestinal osmoreceptors may increase renal sodium excretion, the physiological role of these receptors remains controversial. The purpose of this study was to compare the responses to intragastric hypertonic and isotonic salt loading. Identical amounts of sodium were administered through a nasogastric tube either as a 5% solution or as a 0.9% solution. The results were compared with the effects of oral water loading. Provided that gastrointestinal osmoreceptors play an important role in sodium homeostasis, it was to be expected that the natriuresis following hypertonic saline would exceed the response to isotonic saline and water loading, since only the former increases portal sodium concentration.
| |
METHODS |
|---|
|
|
|---|
Experiments were performed in eight healthy male volunteers. Subjects were 24-30 yr old and weighed 73.9-84.6 kg. All gave informed consent, and the study was approved by the Ethics Committee of Copenhagen (j.nr. KF 01-011/96).
Approximately 2 wk before the experiments, each subject's extracellular volume (ECV) was determined as the distribution volume of [51Cr]EDTA according to the method described by Brøchner-Mortensen (6). On the same day, lean body mass (LBM) was determined by counting the naturally present radionuclide 40K in a whole body counter (NE 8114 3pi, Plastic Scintillator System Nuclear Enterprise) according to Hassager et al. (19). Total body water was then calculated from LBM by multiplication by a factor 0.72 kgH2O/kg LBM. Determinations of total body water and ECV as well as all experiments were performed after the subjects had been on a controlled diet containing 150 mmol NaCl/day for 4 days. Sodium turnover was assessed by measuring 24-h urinary sodium excretion on the day before the experiment.
The night before the experiment the subject slept at the laboratory. At 0700 h, he was awakened and consumed a light standardized low-salt breakfast (3 slices of toast, 15 g marmalade, and 500 ml tap water). The subject was instrumented with two catheters (Venflon, 18 gauge) in superficial cubital veins for blood sampling and injection of saline. After the catheters were inserted, the subject emptied his bladder and was weighed. The subject remained supine throughout the study and was allowed to stand up only for micturition. Initial hydration status was maintained throughout the experiment by drinking water in amounts equal to those voided plus 1 ml/min as replacement for the insensible water loss minus the volume of saline injected intravenously to maintain sodium balance (see below). Room temperature was kept at ~24°C.
Each experiment lasted 8 h and was divided into 1-h periods. After 1 h of baseline, a soft nasogastric polyurethane tube (Ch. 8, Meda) was introduced after local anesthesia with lidocaine. The position of the tube in the ventricle was verified by brief aspiration of gastric juice. Saline was infused through the tube over the first 30 min of period 2, after which it was gently removed. After period 2, sampling continued for another six periods. Two series of saline infusion were performed. In the one series (Isot), the salt load was infused as isotonic saline in amounts equal to 10% of measured ECV (1.44 ± 0.01 liters of 0.9% saline). In the other series (Hyper), an identical amount of sodium was infused as a hypertonic solution (0.26 ± 0.01 liters of 5% saline). Infusions were administered by an automatic infusion pump (LifeCare pump, model 4, Abbott). In an additional series (water), infusion of saline was replaced by drinking of tap water in amounts equal to 3.5% of measured total body water (1.46 ± 0.03 liters of water). The protocol of the time control series (control) was identical to the infusion series, but without infusion. All experiments were performed on separate days with at least 2 wk of recovery between experiments.
Urine was collected by voluntary micturition during the last minute of every hour. After each urine collection, urinary concentration of sodium was measured, and the excreted amount of sodium was replaced by intravenous injection of isotonic saline in the beginning of the subsequent period to maintain the sodium load. The volume of water administered orally to maintain hydration status was reduced correspondingly (see above).
Blood (12 ml) was sampled in heparinized tubes at the beginning and the
end of the baseline period, just after the end of saline infusion, and
in the middle of every remaining 1-h period for measurements of sodium,
osmolality, hematocrit, protein, albumin, creatinine, and oncotic
pressure. Additional blood samples for hormone analyses (20 ml) were
collected in prechilled polyethylene tubes containing aprotinin (300 KIU/ml) and EDTA (3 µmol/ml) in periods 1, 2,
4, 6, and 8. The withdrawn blood was replaced
by twice the amount of saline. Blood samples were centrifuged at +4°C, and plasma was stored at
18°C until later analysis
for concentrations of ANG II and atrial natriuretic peptide (ANP).
Hematocrit was determined by centrifugation (Microfuge, Christ). Oncotic pressure was determined by a colloid osmometer (4400 Colloid Osmometer, Wescor). Hemoglobin and plasma concentrations of albumin and protein were measured by a SMAC3 instrument (Bayer). Urine and plasma sodium concentrations were measured by an ion-selective electrode system (KNA-2, Radiometer), and osmolality was measured by freezing-point depression (model 3DII, Advanced Instruments). Concentrations of creatinine were measured by conventional spectrophotometry.
Arterial systolic and diastolic pressures were recorded semiautomatically four times during each experimental period (Propaq 102, Dameca), and the mean of these values was used to calculate mean arterial pressure (MAP) from the following formula: MAP = diastolic pressure + 1/3 × pulse pressure.
Hormone concentrations in plasma and urine samples were quantified by
radioimmunoassays after extraction. Thawed samples were acidified with
4% acetic acid, and peptides were extracted by use of C18
Sep-Pak cartridges (Waters), as previously described (14). After
elution, the samples were dried and stored at
18°C in tubes
topped with N2 until analysis for hormone immunoreactivity. ANP was determined according to the assay procedure described earlier
(35) by use of an antibody (RAS8798) purchased from Peninsula
Laboratories. Extraction recovery was 85%. Detection limit was 1.5 pg/ml sample, and intra-assay coefficient of variation was 6%.
Immunoreactivity of ANG II was determined by use of an antibody
(Ab-5-030682) produced by P. Christensen. The assay procedure has
been described by Kappelgaard et al. (22). Extraction recovery was
83%. Detection limit was 1.4 pg/ml sample. Intra-assay and interassay
coefficients of variation were 5 and 16%, respectively. The procedure
for measuring endothelin-1 concentrations in extracted urine samples
has been described previously (13). The detection limit was 0.16 pg/ml
urine, and extraction recovery was 91%. Intra-assay and interassay
coefficients of variation were 5.2 and 6.5%, respectively. Samples for
measurements of plasma arginine vasopressin (AVP) were collected, but
the assay failed for technical reasons and the samples were lost.
Hormone results have not been corrected for incomplete recovery.
Time control results have recently been presented as part of another study describing the effects of intravenous salt loading (2).
Statistics. Results are presented as means ± SE. Data were subjected to one-way ANOVA for repeated measures (39). In case of significantly large F values, all possible differences were evaluated by Newman-Keuls test. Selected differences between series were evaluated using paired Student's t-test. Level of significance was in all cases 0.05.
| |
RESULTS |
|---|
|
|
|---|
Total body water calculated from 40K measurements varied between 38.7 and 45.0 liters with a mean of 41.6 ± 0.8 liters (52.5 ± 1.2% of body wt). ECV varied between 13.9 and 14.8 liters with a mean of 14.4 ± 0.1 liters (18.1 ± 0.2% of body wt). Twenty-four-hour sodium excretion was 142 ± 6 mmol during the last day of controlled sodium intake.
Plasma sodium concentration and osmolality increased immediately after
infusion of hypertonic saline and remained elevated throughout the
observation period (Fig. 1). During Isot
and control, plasma sodium concentration remained unchanged, whereas
plasma osmolality decreased slightly but significantly. Plasma sodium as well as plasma osmolality decreased markedly during water (Fig. 1).
|
Oncotic pressure and plasma protein decreased very similarly during
Isot and Hyper (Fig. 2). The same variables
also tended to decrease during water and control, but the decreases
were smaller and more gradual than during Isot and Hyper (Fig. 2).
Hematocrit and plasma albumin followed a very similar pattern.
Hematocrit decreased from 42.8 ± 0.9 to 40.1 ± 0.9% and from 43.1 ± 0.8 to 39.9 ± 1.1% during Isot and Hyper, respectively. Smaller
decreases from 43.2 ± 0.8 to 41.8 ± 0.9% and from 43.4 ± 0.9 to
41.7 ± 0.8% were observed during control and water, respectively.
Plasma albumin decreased from 631 ± 9 to 582 ± 7 µM during Isot,
from 639 ± 10 to 587 ± 9 µM during Hyper, and from 631 ± 6 to
604 ± 10 µM during water but remained unchanged during control.
|
Sodium excretion increased in all experimental series (Fig.
3). At no time did the natriuresis during
Hyper exceed that during Isot. In periods 6 and 7,
hypertonic saline actually induced a significantly smaller natriuresis
than isotonic saline (253 ± 26 and 261 ± 25 vs. 390 ± 39 and 383 ± 47 µmol/min). Measured as cumulated sodium excretion, isotonic
saline also induced the greatest natriuresis, and the response to
hypertonic saline was not significantly greater than that observed
during water or control (Fig. 3).
|
Urine flow and free water clearance increased in all experimental
series except during Hyper in which urine flow remained low and free
water clearance decreased (Fig. 4).
|
MAP increased slightly but consistently during water and Isot. This was
due to increases in diastolic pressure since systolic arterial pressure
remained unchanged (Table 1). During Hyper, diastolic and MAP increased only transiently. During control, there was
only an inconsistent increase in diastolic arterial pressure. Heart
rate tended to decrease in all series in a very similar way, but the
decrease was only statistically significant during control. There were
no significant changes in creatinine clearance (Table 1).
|
Plasma concentrations of ANG II decreased immediately after both
salt-loading procedures but also decreased somewhat during control and
water (Fig. 5). From period 4 to
8, plasma ANG II remained suppressed to 22 ± 6, 35 ± 6, 47 ± 5, and 61 ± 6% of preinfusion levels during Isot, Hyper, water,
and control, respectively. Basal plasma concentrations of ANG II varied
between series (Fig. 5). Samples were not measured in the same assay,
which may explain at least some of this variation. Basal plasma
concentrations of ANP varied between 31 ± 2 and 41 ± 6 pg/ml and
were not affected by any of the loading procedures (Fig. 5). Urinary
excretion rates of endothelin-1 varied between 14 ± 5 and 19 ± 3 pg/min and also remained statistically unchanged in all series.
|
| |
DISCUSSION |
|---|
|
|
|---|
The purpose of this study was to test the hypothesis that intragastric infusion of hypertonic saline induces a greater natriuresis than infusion of the same amount of salt as an isotonic solution because of stimulation of gastrointestinal osmoreceptors involved in the control of renal sodium excretion. However, the results were unable to support the hypothesis, since the natriuresis during Hyper was actually smaller than that observed during Isot.
The implicit assumption of the present experimental design is that intragastric infusion of hypertonic saline induces an increase in sodium concentration of the portal blood that is not obtained with infusion of isotonic saline. This increase in sodium concentration is hypothesized to stimulate osmoreceptors located in the intestines or the liver. If the hypothetical gastrointestinal osmoreceptors play an important role in sodium homeostasis compared with the well-known effect of volume expansion, the hypertonic load should induce a greater natriuresis than the isotonic load. Similarly, the decrease in portal sodium concentration after water loading should be expected to decrease renal sodium excretion. The stimulus used in the present investigation (~220 mmol) is physiological relevant and close to the average daily dietary sodium intake in Western Europe and North America. To minimize the variation in response between subjects, the degree of salt and water loading was determined by the respective spaces of distribution, i.e., by the individually measured ECV and total body water.
Stimulation of gastrointestinal osmoreceptors . It was not possible to measure sodium concentration in the portal blood. However, measurements from the systemic circulation may be used as an index of changes in the blood supplying the gastrointestinal osmoreceptors. It is assumed that, during intragastric hypertonic saline infusion, the sodium concentration of portal blood is at least as high as that of the systemic circulation. In fact, sodium concentration in the portal circulation should markedly exceed that of the systemic circulation, since by the time of peripheral blood sampling, the portal blood has been diluted by mixing of blood from extra-abdominal vascular beds. As expected, plasma sodium concentration and plasma osmolality increased immediately after administration of the hypertonic load as an indication of absorption of the salt load from the gut (Fig. 1). It could be argued that different fractions of the load were absorbed from the intestines during different protocols. However, the two salt-loading procedures induced similar decreases in hematocrit, plasma protein, plasma albumin, and oncotic pressure, indicating that the increases in ECV were identical in the two situations. It is therefore highly unlikely that the absorption of salt from the intestines was less complete during Hyper than during Isot. Finally, systemic plasma tonicity was markedly reduced after water loading, and it appears perfectly reasonable to assume that gastrointestinal osmoreceptors were activated during Hyper, deactivated during water, and unaffected during Isot and control.
Contribution of gastrointestinal osmoreceptors in the natriuretic response to salt loading. At no time did sodium excretion during Hyper exceed that observed during Isot (Fig. 3). In periods 6 and 7, the natriuresis following hypertonic saline loading was actually significantly smaller than the response to isotonic saline loading. Furthermore, the natriuresis following hypertonic loading only exceeded the response to water loading during one of the eight observation periods despite the marked and opposite deviations in plasma osmolality and sodium concentration induced by the two perturbations. It is, therefore, not very likely that stimulation of gastrointestinal osmoreceptors participated in the natriuretic responses to intragastric salt loading under the present circumstances. To our knowledge, intragastric hypertonic and isotonic saline loading has not been performed before in the same subjects. However, others have compared the renal effects of oral vs. intravenous salt loading (7, 8, 18, 24, 29, 36). Lennane et al. (24) and Carey (7) found that normal subjects excreted a hypertonic sodium load more rapidly when it was administered orally than intravenously, supporting the existence of a splanchnic sodium input monitor regulating renal sodium excretion. Their investigations were performed on sodium-depleted subjects, and some of the discrepancies between these and the present results may be due to the differences between the protocols. Possibly, osmoregulatory control of sodium excretion may only be measurable within certain limits of sodium status. However, very recently, Singer et al. (36) were unable to show an excess natriuresis after oral administration of a sodium load in subjects on very low sodium intake (~10 mmol/day) as well as in subjects on high sodium (~350 mmol/day). In subjects on normal sodium intake (~150 mmol/day), sodium excretion was initially lower after oral compared with intravenous salt loading, but 3 h after administration, oral loading induced an excess natriuresis. However, cumulated excretions were statistically identical (36). In separate experiments, we have infused isotonic and hypertonic salt loads intravenously into the same subjects in doses identical to those of the present study (2). Because the experimental setup was identical to the present apart from the route of administration and the time of infusion (90 min), the results are directly compatible. Intravenous infusion of isotonic and hypertonic saline increased renal sodium excretion from 99 ± 19 to 414 ± 29 µmol/min and from 84 ± 10 to 349 ± 33 µmol/min, respectively (2). In this study, intragastric isotonic and hypertonic saline increased sodium excretion from 104 ± 15 to 406 ± 39 µmol/min and from 85 ± 15 to 325 ± 39 µmol/min, respectively. Accordingly, intragastric administration of neither isotonic nor hypertonic saline induced a natriuresis that exceeded the response to the corresponding intravenous loading procedure. Taken together, these findings are not in favor of the hypothesis that increased portal sodium concentration acts as an important stimulus to renal sodium excretion in humans. Similarly, others have also been unable to detect the function of gastrointestinal or hepatic osmoreceptors under physiological conditions (4, 16, 18, 23, 32, 34).
Natriuretic mechanisms . As pointed out previously (2), data from control show that the supine position does not provide a stable baseline with regard to renal excretory function. In contrast, the seated position provides stable time control conditions (3). Therefore, the position of the subjects must be carefully considered in future human studies of water and electrolyte homeostasis.
Plasma ANG II is probably the main controller of the natriuretic response to intravenous saline loading (2, 3, 37). Plasma ANG II also decreased in all experimental series in the present study. Relatively, the most pronounced decrease was observed during Isot, which was associated with the greatest natriuresis. We find it likely that ANG II plays a pivotal role in the natriuresis of salt loading irrespective of the route of administration, a notion that is supported by the findings of Singer and co-workers (36, 37). In contrast, plasma ANP was unaffected by intragastric infusion of hypertonic and isotonic saline infusion, and it seems unlikely that ANP contributed to the natriuresis during any of the loading procedures. Singer et al. (36) also observed that plasma ANP was unaffected by oral sodium loading, whereas secretion was stimulated after intravenous loading in subjects on normal and high sodium intake. Previously, we have observed marked natriurises following intravenous administration of isotonic as well as hypertonic saline without measurable increases in plasma ANP levels (2, 3, 15). Although long-term changes in sodium intake may be reflected in plasma ANP levels (3, 36), the role of ANP in the response to acute sodium loading seems less clear. Possibly, short-term regulation of ANP secretion is rate sensitive and plasma ANP is only increased after relatively rapid intravenous salt loading, whereas procedures involving smaller rates of increases, e.g., intestinal absorption or slow infusion, fail to stimulate ANP secretion (3, 36). Urinary excretion of endothelin-1 was also unaffected by the salt loading, and the observed changes in sodium excretion cannot be attributed to changes in this parameter. Plasma AVP concentration most likely increased during Hyper and decreased in all the other series. This notion is supported by the observed changes in urine flow and free water clearance. Because there is indication that a physiological increase in plasma AVP concentration may promote antinatriuresis in humans (1), it is possible that part of the increase in sodium excretion during Isot, control, and especially during water was induced by a fall in plasma AVP. Similarly, the natriuresis during Hyper may have been inhibited by an increase in plasma AVP concentration. Accordingly, the surprisingly small differences between sodium excretions during Hyper and water may be accounted for by opposite changes in plasma AVP. It is generally accepted that an increase in arterial blood pressure may induce pressure natriuresis. Previously we have not observed any increases in arterial pressure in response to intravenous administration of similar doses of sodium (3), but during Isot, MAP increased slightly but significantly. During Hyper, only a transient increase was observed. It is possible that the rises in arterial pressure contributed to the natriureses in the present study. However, it is noteworthy that the most consistent increase in MAP was observed during water, indicating the increase in arterial pressure may not necessarily be related to the degree of extracellular volume expansion. A decrease in oncotic pressure has been found to be a strong natriuretic stimulus in dogs (9) and humans (21). Because oncotic pressure decreased in all series in parallel with the observed changes in sodium excretion, it is very likely that dilution of plasma was responsible for part of the natriuretic responses. The effect on sodium excretion may be mediated by the direct changes in the physical forces working on the formation of the ultrafiltrate and on the rate of reabsorption in the tubules, but it may also be mediated by a decrease in the activity of the renin-angiotensin system (21). Creatinine clearance did not change measurably, but it must be considered that this parameter is not a very precise estimate of glomerular filtration rate in humans.Limitations of the study . The present study is performed under strictly controlled and well-defined conditions with regard to sodium status, individual adjustment of dosage, replacement of water, and salt losses throughout the study. Salt loads were administered through a gastric tube, eliminating possible sensory inputs (e.g., salt taste) associated with oral salt loading. The fact that the results were unable to support our hypothesis may be explained by the absence of an important role of gastrointestinal osmoreceptors in sodium homeostasis in normal, sodium-replete subjects. However, there are certain limitations to the design of the study. First of all, the precise location of the gastrointestinal osmoreceptors is unknown, and the exact stimulus cannot be determined because of lack of portal blood samples. Although there is indication that the degree of absorption of sodium was similar during Hyper and Isot, it is possible that the intestinal salt absorption rates were dissimilar in the two series, thus creating dissimilar rates of changes in the ECV. Finally, a possible contribution of osmoreceptors in the regulation of sodium excretion may be overridden by the natriuretic effect of the concomitant volume expansion-induced isotonic as well as hypertonic salt loading.
Summary and conclusion . Intragastric infusion of hypertonic saline did not induce a natriuresis that exceeded that induced by isotonic saline. Furthermore, the cumulated sodium excretion after hypertonic saline did not significantly exceed that after oral water loading. Therefore, we conclude that stimulation of gastrointestinal osmoreceptors was not responsible for the natriuresis of intragastric salt loading in these supine subjects. The natriuretic responses to all the loading procedures were preceded by decreases in plasma ANG II concentration, but no changes were observed in plasma ANP or urinary excretion rate of endothelin-1.
Perspectives
The results were unable to support the notion that renal sodium handling following intragastric salt loading is influenced by gastrointestinal or hepatic osmoreceptors. Instead, the data emphasize the importance of well-known systemic factors in control of sodium excretion, i.e., the renin-angiotensin-aldosterone system. Most experiments dealing with the role of gastrointestinal osmoreceptors have been performed in animals, but the present data indicate a need for implementation of human investigations to clarify the physiological role of gastrointestinal osmoreceptors in sodium homeostasis. Such investigations should be performed in the sitting position to ensure stable baseline conditions and include detailed analysis of the classical control systems.| |
ACKNOWLEDGEMENTS |
|---|
We thank Bodil Svensson, Birthe Lynderup Christensen, Sigurd Kramer Hansen, Inge Pedersen, Barbara Sørensen, and Trine Eidsvold for expert technical assistance. We also acknowledge the expert assistance of Dr. Steen Levin Nielsen in calculations of the subjects' extracellular volume and the expert assistance of Dr. Sven Sølvsten Sørensen in measurements of the subjects' total body potassium.
| |
FOOTNOTES |
|---|
Preliminary results were presented at Experimental Biology 98 in San Francisco, California, in April 1998.
The experiments were supported by the Danish Medical Research Council, the Danish Foundation for the Advancement of Medical Science, the Kong Christian den Tiendes Foundation, the Engineer August Frederik Wedell Erichsens Foundation, the Direktør Jacob Madsens and Hustru Olga Madsens Foundation, and the Danish Heart Foundation.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: P. Bie, Dept. of Physiology and Pharmacology, University of Southern Denmark, 21 Winsløwparken, DK-5000 Odense, Denmark (E-mail: bie{at}imbmed.sdu.dk).
Received 20 October 1998; accepted in final form 3 August 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Andersen, L. J.,
J. L. Andersen,
H. J. Schütten,
J. Warberg,
and
P. Bie.
Antidiuretic effect of subnormal levels of arginine vasopressin in normal humans.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
259:
R53-R60,
1990
2.
Andersen, L. J.,
T. U. S. Jensen,
M. H. Bestle,
and
P. Bie.
Isotonic and hypertonic sodium loading in supine humans.
Acta Physiol. Scand.
166:
23-30,
1999[Web of Science][Medline].
3.
Andersen, L. J.,
P. Norsk,
L. B. Johansen,
P. Christensen,
T. Engstrøm,
and
P. Bie.
Osmoregulatory control of renal sodium excretion after sodium loading in humans.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
275:
R1833-R1842,
1998
4.
Bennett, W. M.,
D. Hennes,
D. Elliot,
and
G. A. Porter.
In search of a hepatic osmoreceptor in man.
Dig. Dis.
19:
143-148,
1974.
5.
Bourque, C. W.,
S. H. R. Oliet,
and
D. Richard.
Osmoreceptors, osmoreception, and osmoregulation.
Front. Neuroendocrinol.
15:
231-274,
1994[Web of Science][Medline].
6.
Brøchner-Mortensen, J.
The extracellular fluid volume in normal man determined as the distribution volume of [51Cr]EDTA.
Scand. J. Clin. Lab. Invest.
42:
261-264,
1982[Web of Science][Medline].
7.
Carey, R. M.
Evidence for a splanchnic sodium input monitor regulating renal sodium excretion in man. Lack of dependence upon aldosterone.
Circ. Res.
43:
19-23,
1978
8.
Carey, R. M.,
J. R. Smith,
and
E. M. Ortt.
Gastrointestinal control of sodium excretion in sodium-depleted conscious rabbits.
Am. J. Physiol.
230:
1504-1508,
1976.
9.
Cowley, A. W., Jr.,
and
M. M. Skelton.
Dominance of colloid osmotic pressure in renal excretion after isotonic volume expansion.
Am. J. Physiol. Heart Circ. Physiol.
261:
H1214-H1225,
1991
10.
Daly, J. J.,
J. W. Roe,
and
P. Horrocks.
A comparison of sodium excretion following the infusion of saline into systemic and portal veins in the dog: evidence for a hepatic role in the control of sodium excretion.
Clin. Sci.
33:
481-487,
1967[Web of Science][Medline].
11.
Dennhardt, R.,
W. W. Ohm,
and
F. J. Haberich.
The elimination of the hepatic branches of the vagal nerve of conscious rats and its influence on the hepatogenous diuresis: indirect evidence for the afferent vagal pathway of the hepatic osmoreceptors.
Pflügers Arch.
328:
51-56,
1971[Web of Science][Medline].
12.
Duggan, K. A.,
D. M. Jones,
and
G. J. MacDonald.
Participation of the renin-angiotensin system in regulating the excretory response to acute sodium ingestion.
Clin. Exp. Pharmacol. Physiol.
22:
455-456,
1995[Web of Science][Medline].
13.
Emmeluth, C.,
C. Drummer,
R. Gerzer,
and
P. Bie.
Roles of cephalic Na+ concentration and urodilatin in control of renal Na+ excretion.
Am. J. Physiol. Renal Fluid Electrolyte Physiol.
262:
F513-F516,
1992
14.
Emmeluth, C.,
C. Drummer,
R. Gerzer,
and
P. Bie.
Natriuresis in conscious dogs caused by increased carotid [Na+] during angiotensin II and aldosterone blockade.
Acta Physiol. Scand.
151:
403-411,
1994[Web of Science][Medline].
15.
Emmeluth, C.,
H. J. Schütten,
U. Knigge,
J. Warberg,
and
P. Bie.
Increase in plasma sodium enhances natriuresis in response to a sodium load unable to change plasma atrial peptide concentration.
Acta Physiol. Scand.
140:
119-127,
1990[Web of Science][Medline].
16.
Glasby, M. A.,
and
D. J. Ramsay.
Hepatic osmoreceptors?
J. Physiol. (Lond.)
243:
765-776,
1974
17.
Haberich, F. J.,
O. Aziz,
P. E. Nowacki,
and
W. Ohm.
On the specificity of osmoreceptors in the liver.
Pflügers Arch.
313:
289-299,
1969[Web of Science][Medline].
18.
Hanson, R. C.,
L. A. McLane-Vega,
J. W. Childers,
S. D. Gleason,
and
E. G. Schneider.
Lack of evidence for gastrointestinal control of sodium excretion in unanesthetized dogs.
Am. J. Physiol. Renal Fluid Electrolyte Physiol.
238:
F112-F118,
1980.
19.
Hassager, C.,
S. S. Sørensen,
B. Nielsen,
and
C. Christiansen.
Body composition measurement by dual photon absorptiometry: comparison with body density and total body potassium measurements.
Clin. Physiol.
9:
353-360,
1989[Web of Science][Medline].
20.
Hosomi, H.,
and
H. Morita.
Hepatorenal and hepatointestinal reflexes in sodium homeostasis.
News Physiol. Sci.
11:
103-107,
1996
21.
Johansen, L. B.,
B. Pump,
J. Warberg,
N. J. Christensen,
and
P. Norsk.
Preventing hemodilution abolishes natriuresis of water immersion in humans.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
275:
R879-R888,
1998
22.
Kappelgaard, A. M.,
M. D. Nielsen,
and
J. Giese.
Measurement of angiotensin II in human plasma: technical modifications and practical experience.
Clin. Chim. Acta
67:
299-306,
1976[Web of Science][Medline].
23.
Kapteina, F. W.,
W. Motz,
D. Schwartz-Porsche,
and
O. H. Gauer.
Comparison of renal responses to 5% saline infusions into vena portae and vena cava in conscious dogs.
Pflügers Arch.
374:
23-29,
1978[Web of Science][Medline].
24.
Lennane, R. J.,
R. M. Carey,
T. J. Goodwin,
and
W. S. Peart.
A comparison of natriuresis after oral and intravenous sodium loading in sodium-depleted man: evidence for a gastrointestinal or portal monitor of sodium intake.
Clin. Sci. Mol. Med.
49:
437-440,
1975[Web of Science][Medline].
25.
Morita, H.,
Q. Chen,
and
H. Hosomi.
Role of hepatic nerves in long-term control of NaCl homeostasis in Wistar-Kyoto rats.
J. Auton. Nerv. Syst.
54:
9-15,
1995[Web of Science][Medline].
26.
Morita, H.,
K. Ishiki,
and
H. Hosomi.
Effects of hepatic NaCl receptor stimulation on renal nerve activity in conscious rabbits.
Neurosci. Lett.
123:
1-3,
1991[Web of Science][Medline].
27.
Morita, H.,
T. Matsuda,
F. Furuya,
M. R. Khanchowdhury,
and
H. Hosomi.
Hepatorenal reflex plays an important role in natriuresis after high-NaCl food intake in conscious dogs.
Circ. Res.
72:
552-559,
1993
28.
Morita, H.,
Y. Nishida,
and
H. Hosomi.
Neural control of urinary sodium excretion during hypertonic NaCl load in conscious rabbits: role of renal and hepatic nerves and baroreceptors.
J. Auton. Nerv. Syst.
34:
157-169,
1991[Web of Science][Medline].
29.
Mu, J. Y.,
G. C. Hansson,
G. Bergström,
and
O. Lundgren.
Renal sodium excretion after oral or intravenous sodium loading in sodium-deprived normotensive and spontaneously hypertensive rats.
Acta Physiol. Scand.
153:
169-177,
1994[Web of Science].
30.
Mu, J. Y.,
M. Johansson,
and
O. Lundgren.
The effects of enalapril on the natriuretic response evoked by an oral sodium load in sodium deprived normotensive and hypertensive rats.
Acta Physiol. Scand.
160:
157-164,
1997[Web of Science][Medline].
31.
Passo, S. S.,
J. R. Thornborough,
and
A. B. Rothballer.
Hepatic receptors in control of sodium excretion in anesthetized cats.
Am. J. Physiol.
224:
373-375,
1973.
32.
Potkay, S.,
and
J. P. Gilmore.
Renal responses to vena caval and portal venous infusions of sodium chloride in unanaesthetized dogs.
Clin. Sci.
39:
13-20,
1970[Web of Science][Medline].
33.
Sawchenko, P. E.,
and
M. I. Friedman.
Sensory functions of the liver: a review.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
236:
R5-R20,
1979
34.
Schneider, E. G.,
J. O. Davis,
C. A. Robb,
J. S. Baumber,
J. A. Johnson,
and
F. S. Wright.
Lack of evidence for a hepatic osmoreceptor mechanism in conscious dogs.
Am. J. Physiol.
218:
42-45,
1970.
35.
Schütten, H. J.,
A. C. Johannessen,
C. Torp-Pedersen,
K. Sander-Jensen,
P. Bie,
and
J. Warberg.
Central venous pressure: a physiological stimulus for secretion of atrial natriuretic peptide in humans?
Acta Physiol. Scand.
131:
265-272,
1987[Web of Science][Medline].
36.
Singer, D. R. J.,
N. D. Markandu,
M. G. Buckley,
M. A. Miller,
G. A. Sagnella,
and
G. A. MacGregor.
Contrasting endocrine responses to acute oral compared with intravenous sodium loading in normal humans.
Am. J. Physiol. Renal Physiol.
274:
F111-F119,
1998
37.
Singer, D. R.,
N. D. Markandu,
J. J. Morton,
M. A. Miller,
G. A. Sagnella,
and
G. A. MacGregor.
Angiotensin II suppression is a major factor permitting excretion of an acute sodium load in humans.
Am. J. Physiol. Renal Fluid Electrolyte Physiol.
266:
F89-F93,
1994
38.
Strandhoy, J. W.,
and
H. E. Williamson.
Evidence for a hepatic role in the control of sodium excretion.
Proc. Soc. Exp. Biol. Med.
133:
419-422,
1970[Medline].
39.
Winer, B. J.
Statistical Methods in Experimental Design (2nd ed.). New York: McGraw-Hill, 1971.
This article has been cited by other articles:
![]() |
S. Molstrom, N. H. Larsen, J. A. Simonsen, R. Washington, and P. Bie Normotensive sodium loading in normal man: regulation of renin secretion during {beta}-receptor blockade Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R436 - R445. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kompanowska-Jezierska, H. Wolff, M. Kuczeriszka, J. B. Gramsbergen, A. Walkowska, E. J. Johns, and P. Bie Renal nerves and nNOS: roles in natriuresis of acute isovolumetric sodium loading in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1130 - R1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Holte, N. E. Sharrock, and H. Kehlet Pathophysiology and clinical implications of perioperative fluid excess Br. J. Anaesth., October 1, 2002; 89(4): 622 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Andersen, J. L. Andersen, B. Pump, and P. Bie Natriuresis induced by mild hypernatremia in humans Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1754 - R1761. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Skott Renin Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R937 - R939. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |